| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 120,000 | 12 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VIRX | Viracta Therapeutics, Inc. | 12 Mar 2024 | 1 | $0 | 4 | Chief Medical Officer | 13 Mar 2024, 20:33 |
| VIRX | Viracta Therapeutics, Inc. | 16 Aug 2023 | 2 | $0 | 4 | Chief Medical Officer | 18 Aug 2023, 17:46 |
| VIRX | Viracta Therapeutics, Inc. | 07 Aug 2023 | 0 | $0 | 3 | Chief Medical Officer | 16 Aug 2023, 18:58 |